Menopause hormonal therapy from the urologist’s perspective Deborah J. Lightner Invited Commentary Pages: 1 - 3
Designing clinical trials for kidney cancer based on newly developed prognostic and predictive tools Daniel ChoDavid McDermottMichael Atkins OriginalPaper Pages: 8 - 15
Novel kinase inhibitors in renal cell carcinoma: Progressive development of static agents Apurva A. DesaiWalter M. Stadler OriginalPaper Pages: 16 - 22
Minimally invasive management of upper tract urothelial carcinoma Fadi N. JoudiCurtis N. CraneMichael A. O’Donnell OriginalPaper Pages: 23 - 30
Open partial nephrectomy for the treatment of renal cell carcinoma Brian ShuchJohn S. LamArie S. Belldegrun OriginalPaper Pages: 31 - 38
Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure Steve J. HodgesAnthony Atala Clinical Trials Report Pages: 41 - 42
Tissue print micropeel: A new technique for mapping tumor invasion in prostate cancer Sandra M. GastonMelissa P. Upton OriginalPaper Pages: 50 - 56
Cell type-specific analyses for identifying prostate cancer biomarkers Peter S. NelsonBruce Montgomery OriginalPaper Pages: 57 - 63
Laparoscopic adrenalectomy: Determining invasiveness Joseph J. Del Pizzo Clinical Trials Report Pages: 67 - 67
Less invasive diagnosis of cushing’s syndrome Joseph J. Del Pizzo Clinical Trials Report Pages: 67 - 67
Radiofrequency ablation for adrenal lesions Joseph J. Del Pizzo Clinical Trials Report Pages: 68 - 68
Radiographic evaluation of the incidental adrenal lesion Joseph J. Del Pizzo OriginalPaper Pages: 69 - 72
Adrenocortical hypertension Angelo CapricchioneNathaniel WinerJames R. Sowers OriginalPaper Pages: 73 - 79
Adrenal insuficiency: Diagnosis and management Ravi MunverIlya A. Volfson OriginalPaper Pages: 80 - 85
Phase-ii study of pomegranate juice for men with prostate cancer and increasing psa Allan J. PantuckNazy ZomorodianArie S. Belldegrun Clinical Trials Report Pages: A1 - A1
